“Sofosbuvir Plus Daclatasvir Without Ribavirin for the Treatment of Chronic Hepatitis C in Patients With Decompensated Liver Disease: Response of Sofosbuvir Plus Daclatasvir in Decompensated Cirrhosis”. 2020. Journal of Fatima Jinnah Medical University 14 (1): 41-44. https://doi.org/10.37018/WOXS1774.